Works matching IS 00071048 AND DT 2018 AND VI 182 AND IP 3

Results: 24
    1

    Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 412, doi. 10.1111/bjh.15406
    By:
    • Klintman, Jenny;
    • Barmpouti, Katerina;
    • Knight, Samantha J. L.;
    • Robbe, Pauline;
    • Dreau, Hélène;
    • Clifford, Ruth;
    • Ridout, Kate;
    • Burns, Adam;
    • Timbs, Adele;
    • Bruce, David;
    • Antoniou, Pavlos;
    • Sosinsky, Alona;
    • Becq, Jennifer;
    • Bentley, David;
    • Hillmen, Peter;
    • Taylor, Jenny C.;
    • Caulfield, Mark;
    • Schuh, Anna H.
    Publication type:
    Article
    2

    Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 404, doi. 10.1111/bjh.15411
    By:
    • Jain, Preetesh;
    • Romaguera, Jorge;
    • Srour, Samer A.;
    • Lee, Hun J.;
    • Hagemeister, Frederick;
    • Westin, Jason;
    • Fayad, Luis;
    • Samaniego, Felipe;
    • Badillo, Maria;
    • Zhang, Liang;
    • Nastoupil, Lorreta;
    • Kanagal‐Shamanna, Rashmi;
    • Fowler, Nathan;
    • Wang, Michael L.
    Publication type:
    Article
    3
    4

    Transcriptomic rationale for synthetic lethality‐targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 373, doi. 10.1111/bjh.15408
    By:
    • Hurtado, Ana M.;
    • Luengo‐Gil, Gines;
    • Chen‐Liang, Tzu H.;
    • Amaral, Fabio;
    • Batta, Kiran;
    • Palomo, Laura;
    • Lumbreras, Eva;
    • Przychodzen, Bartlomiej;
    • Caparros, Eva;
    • Amigo, Marıa L.;
    • Dıez‐Campelo, Maria;
    • Zamora, Lurdes;
    • Salido Fierrez, Eduardo J.;
    • Maciejewski, Jaroslaw P.;
    • Ortuño, Francisco J.;
    • Vicente, Vicente;
    • del Canizo, Marıa;
    • Sole, Francesc;
    • Ferrer‐Marin, Francisca;
    • Wiseman, Daniel H.
    Publication type:
    Article
    5

    Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 418, doi. 10.1111/bjh.15407
    By:
    • McLornan, Donal P.;
    • Szydlo, Richard;
    • Robin, Marie;
    • van Biezen, Anja;
    • Koster, Linda;
    • Blok, Henrik J. P.;
    • Van Lint, Maria T.;
    • Finke, Jürgen;
    • Vitek, Antonin;
    • Carlson, Kristina;
    • Griskevicius, Laimonas;
    • Holler, Ernst;
    • Itälä‐Remes, Maija;
    • Schaap, Michel;
    • Socié, Gerard;
    • Bay, Jacques‐Olivier;
    • Beguin, Yves;
    • Bruno, Benedetto;
    • Cornelissen, Jan J.;
    • Gedde‐Dahl, Tobias
    Publication type:
    Article
    6

    Guideline for the treatment of chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 344, doi. 10.1111/bjh.15460
    By:
    • Schuh, Anna H.;
    • Parry‐Jones, Nilima;
    • Appleby, Niamh;
    • Bloor, Adrian;
    • Dearden, Claire E.;
    • Fegan, Christopher;
    • Follows, George;
    • Fox, Christopher P.;
    • Iyengar, Sunil;
    • Kennedy, Ben;
    • McCarthy, Helen;
    • Parry, Helen M.;
    • Patten, Piers;
    • Pettitt, Andrew R.;
    • Ringshausen, Ingo;
    • Walewska, Renata;
    • Hillmen, Peter
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 429, doi. 10.1111/bjh.14793
    By:
    • Pratt, Guy;
    • Yap, Christina;
    • Oldreive, Ceri;
    • Slade, Daniel;
    • Bishop, Rebecca;
    • Griffiths, Mike;
    • Dyer, Martin J. S.;
    • Fegan, Chris;
    • Oscier, David;
    • Pettitt, Andrew;
    • Matutes, Estella;
    • Devereux, Stephen;
    • Allsup, David;
    • Bloor, Adrian;
    • Hillmen, Peter;
    • Follows, George;
    • Rule, Simon;
    • Moss, Paul;
    • Stankovic, Tatjana
    Publication type:
    Article
    15

    Issue Information.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 309, doi. 10.1111/bjh.14939
    Publication type:
    Article
    16
    17
    18

    A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 442, doi. 10.1111/bjh.14806
    By:
    • Short, Nicholas J.;
    • Kantarjian, Hagop;
    • Jabbour, Elias;
    • Cortes, Jorge E.;
    • Thomas, Deborah A.;
    • Rytting, Michael E.;
    • Daver, Naval;
    • Alvarado, Yesid;
    • Konopleva, Marina;
    • Kebriaei, Partow;
    • Wierda, William G.;
    • DiNardo, Courtney D.;
    • Bivins, Carol;
    • McCue, Deborah;
    • Richie, Mary A.;
    • Ravandi, Farhad
    Publication type:
    Article
    19
    20
    21
    22
    23

    Effect of N‐acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 3, p. 444, doi. 10.1111/bjh.14809
    By:
    • Sins, Joep W. R.;
    • Fijnvandraat, Karin;
    • Rijneveld, Anita W.;
    • Boom, Martine B.;
    • Kerkhoffs, Jean‐Louis H.;
    • van Meurs, Alfred H.;
    • de Groot, Marco R.;
    • Heijboer, Harriët;
    • Dresse, Marie‐Françoise;
    • Lê, Phu Quoc;
    • Hermans, Philippe;
    • Vanderfaeillie, Anna;
    • Van Den Neste, Eric W.;
    • Benghiat, Fleur S.;
    • Kesse‐Adu, Rachel;
    • Delannoy, André;
    • Efira, André;
    • Azerad, Marie‐Agnès;
    • de Borgie, Corianne A.;
    • Biemond, Bart J.
    Publication type:
    Article
    24